The efficacy of VNS in some cases of CDKL5- or MECP2-related epilepsy, Angelman syndrome, and Ring chromosome 20 syndrome or in DRE of other monogenic etiologies (one case) have been previously reported (12–23). This evidence concerns the gene MECP2 and Angelman syndrome.